- 4 سال پیش
- 283
- 04:31
Guideline Made Easy (5)
Daily Cardiology
0
توضیحات
Practical Guide for treatment of high blood cholesterol Part Two
با صدای
دسته بندیها
پزشکی و درمان
رده سنی
محتوای تمیز
تگ ها
Avatar
کاربر شنوتواولین نفر کامنت بزار
CardioPoint (3): NOACs in Elderly
- 292
- 4 سال پیش
A Brief Description on Practical Points in Anticoagulation...
A Brief Description on Practical Points in Anticoa...
06:35
- 292
- 4 سال پیش
06:35
CardioPoint (2): NOAC Monitoring, Do NOACs Need Monitoring?
- 274
- 4 سال پیش
A Brief Description on Practical Points in Anticoagulation...
A Brief Description on Practical Points in Anticoa...
04:50
- 274
- 4 سال پیش
04:50
CardioPoint (1): Statins-Who is eligible?-Which dose?
- 303
- 4 سال پیش
A Brief Description on Practical Points in Cardiometabolic Field...
A Brief Description on Practical Points in Cardiom...
04:32
- 303
- 4 سال پیش
04:32
Rivaroxaban vs Apixaban in major ischemic or hemorrhagic events in AF
- 294
- 4 سال پیش
Rivaroxaban vs Apixaban in AF...
Rivaroxaban vs Apixaban in AF
02:55
- 294
- 4 سال پیش
02:55
Antiplatelet journal scan
- 288
- 4 سال پیش
A review on recent antiplatelet therapy trials...
A review on recent antiplatelet therapy trials
11:57
- 288
- 4 سال پیش
11:57
Landmark trials of ESC 2021 congress
- 306
- 4 سال پیش
2021 post-ESC headlines...
2021 post-ESC headlines
01:33:40
- 306
- 4 سال پیش
01:33:40
Cardio-Watch Podcast: Episode 7, ESC 2021 special
- 274
- 4 سال پیش
The seventh episode of Cardio-Watch: ESC 2021...
The seventh episode of Cardio-Watch: ESC 2021
09:21
- 274
- 4 سال پیش
09:21
Therapeutic anticoagulation with Heparin in critically and non-critically ill patients with COVID-19
- 282
- 4 سال پیش
The role of Heparin in the management of thrombosis in COVID-19...
The role of Heparin in the management of thrombosi...
03:44
- 282
- 4 سال پیش
03:44
Cardio-Watch Podcast: Episode 6, Electrophysiology
- 298
- 4 سال پیش
The sixth episode of Cardio-Watch: Electrophysiology...
The sixth episode of Cardio-Watch: Electrophysiolo...
08:24
- 298
- 4 سال پیش
08:24
تمامی حقوق این وبسایت متعلق به شنوتو است